Anti-Mouse CD273 (B7-DC) FITC

Also known as: B7DC, PD-L2, PDL-2, PDL2

Clone: 122

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 11-9972

Cat. No. Size
11-9972-81 50 ug
11-9972-82 100 ug
11-9972-85 500 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD273 (B7-DC) FITC.

In vitro BALB/c mouse bone marrow-derived dendritic cells were stained with 0.25 ug of Rat IgG2a...View More

  • Data for Anti-Mouse CD273 (B7-DC) FITC.
Description

Description: The 122 monoclonal antibody reacts with mouse B7-DC, also known as PD-L2. B7-DC, a recently identified member of the B7 family, has a predicted molecular weight of approximately 25 kDa and belongs to the Ig superfamily. The mouse B7-DC has a short cytoplasmic tail (4aa). B7-DC is primarily expressed by subpopulations of dendritic cells and monocytes/macrophages in the mouse. Although B7-DC has structural and sequence similarities to the B7 family, it does not bind CD28/CTLA-4, rather it is a ligand for PD-1. The interactions between PD-1 and B7-DC/PD-L2 have been reported to be involved in costimulation or suppression of T cell proliferation depending on state of cellular activation. 122 has been demonstrated to block binding of TY25 (Cat. No. 14-5986), another mAb specific for mouse B7-DC.

Details
Host Rat
Isotype IgG2a, kappa
Reactivity Mouse
Conjugate FITC
Laser Blue Laser
Emit 518 nm
Excite 488 nm
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
12-9972 Anti-Mouse CD273 (B7-DC) PE 488 - 561 nm 575 nm FC RUO
14-9972 Anti-Mouse CD273 (B7-DC) Purified FC RUO
13-9972 Anti-Mouse CD273 (B7-DC) Biotin FC RUO
References

References: Ishida M, Iwai Y, Tanaka Y, Okazaki T, Freeman GJ, Minato N, Honjo T. 2002. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett. 84(1):57-62. Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM. 2002. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 32(3):634-43.